OtherNeuropharmacology
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
Simon Akerman, Holger Kaube and Peter James Goadsby
Journal of Pharmacology and Experimental Therapeutics January 12, 2004, DOI: https://doi.org/10.1124/jpet.103.059808
Simon Akerman
Holger Kaube
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherNeuropharmacology
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
Simon Akerman, Holger Kaube and Peter James Goadsby
Journal of Pharmacology and Experimental Therapeutics January 12, 2004, DOI: https://doi.org/10.1124/jpet.103.059808
OtherNeuropharmacology
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
Simon Akerman, Holger Kaube and Peter James Goadsby
Journal of Pharmacology and Experimental Therapeutics January 12, 2004, DOI: https://doi.org/10.1124/jpet.103.059808
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement